SGLT2-inhibitors are effective and safe in the elderly: The SOLD study.
Lunati ME, Cimino V, Gandolfi A, Trevisan M, Montefusco L, Pastore I, Pace C, Betella N, Favacchio G, Bulgheroni M, Bucciarelli L, Massari G, Mascardi C, Girelli A, Morpurgo PS, Folli F, Luzi L, Mirani M, Pintaudi B, Bertuzzi F, Berra C, Fiorina P.
Lunati ME, et al. Among authors: bulgheroni m.
Pharmacol Res. 2022 Sep;183:106396. doi: 10.1016/j.phrs.2022.106396. Epub 2022 Aug 12.
Pharmacol Res. 2022.
PMID: 35970329